In this case, patentability challenges sought to establish Saint Jude Medical’s freedom to operate in the renal denervation market, which was projected to grow quickly to more than $3 billion annually. Our team served as lead counsel for requester Saint Jude Medical in nine inter partes reexaminations, and every challenged claim was finally adjudicated to be invalid on multiple grounds.

A representative reexamination request can be found here.